Association Briefs

When Jing Jie Yu, an associate professor at the Peking Union Medical College in Beijing, China, attempted to organize scientists and doctors to educate the public about the harmful effects of smoking, she was met by a less-than-enthusiastic Chinese government. Today, three years later, she is a visiting scientist on the Smoking, Tobacco, and Cancer Program at the National Cancer Institute in Bethesda, Md., and, she says, smoking has become an even more serious health threat in her country, espe

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

When Jing Jie Yu, an associate professor at the Peking Union Medical College in Beijing, China, attempted to organize scientists and doctors to educate the public about the harmful effects of smoking, she was met by a less-than-enthusiastic Chinese government. Today, three years later, she is a visiting scientist on the Smoking, Tobacco, and Cancer Program at the National Cancer Institute in Bethesda, Md., and, she says, smoking has become an even more serious health threat in her country, especially because of the increasing presence of Western tobacco companies. According to a report from the American Cancer Society, while tobacco markets are decreasing in industrialized countries at about 1.1% a year, smoking is increasing in nonindustrialized countries at an average of 2.1% a year, outpacing population growth. The Third World has now become a primary target for foreign tobacco companies. Yu says that 250 million Chinese of the country's 1.1 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies